Holdings
Invesco Health Care Fund
As of Jul 31, 2026, Invesco Health Care Fund reported 78 positions worth US$1.18B. Largest: Eli Lilly and Company, Johnson & Johnson and UnitedHealth Group Incorporated. What it bought and sold, with each filing.
Holdings
- Part of
- Invesco
- Positions
- 78
- Value as reported
- US$1.18B
- Holdings as of
- Jul 31, 2026
- Last filed
- Sep 28, 2026
| Company | Shares | Value as reported | % of portfolio | Change | As of |
|---|---|---|---|---|---|
| Eli Lilly and Company NYSE:LLY | 111K | US$128M | 10.6% | −5,504 | Jul 31, 2026 |
| Johnson & Johnson NYSE:JNJ | 318K | US$81.6M | 6.8% | +30,790 | Jul 31, 2026 |
| UnitedHealth Group Incorporated NYSE:UNH | 180K | US$74.4M | 6.2% | +63,953 | Jul 31, 2026 |
| Merck & Company, Inc. NYSE:MRK | 426K | US$55.4M | 4.6% | +191K | Jul 31, 2026 |
| AbbVie Inc. NYSE:ABBV | 194K | US$48.6M | 4.0% | No change | Jul 31, 2026 |
| Gilead Sciences, Inc. NASDAQ:GILD | 337K | US$43.9M | 3.6% | No change | Jul 31, 2026 |
| argenx SE EURONEXT:ARGX | 45,770 | US$39.1M | 3.2% | −7,206 | Jul 31, 2026 |
| CVS Health Corporation NYSE:CVS | 291K | US$30.4M | 2.5% | +66,820 | Jul 31, 2026 |
| Welltower Inc. NYSE:WELL | 120K | US$28.2M | 2.3% | No change | Jul 31, 2026 |
| BrightSpring Health Services, Inc. NASDAQ:BTSG | 445K | US$26.5M | 2.2% | −37,560 | Jul 31, 2026 |
| Royalty Pharma plc NASDAQ:RPRX | 441K | US$25.8M | 2.1% | No change | Jul 31, 2026 |
| Cardinal Health, Inc. NYSE:CAH | 110K | US$25.3M | 2.1% | +7,524 | Jul 31, 2026 |
| Guardant Health, Inc. NASDAQ:GH | 152K | US$24.7M | 2.0% | No change | Jul 31, 2026 |
| Vertex Pharmaceuticals Incorporated NASDAQ:VRTX | 50,958 | US$24.3M | 2.0% | No change | Jul 31, 2026 |
| Axsome Therapeutics, Inc. NASDAQ:AXSM | 87,700 | US$19.1M | 1.6% | No change | Jul 31, 2026 |
| Edwards Lifesciences Corporation NYSE:EW | 219K | US$18.9M | 1.6% | +26,356 | Jul 31, 2026 |
| Thermo Fisher Scientific Inc NYSE:TMO | 32,631 | US$18.7M | 1.6% | +15,027 | Jul 31, 2026 |
| BridgeBio Pharma, Inc. NASDAQ:BBIO | 216K | US$17.3M | 1.4% | No change | Jul 31, 2026 |
| Waters Corporation NYSE:WAT | 45,153 | US$17M | 1.4% | New | Jul 31, 2026 |
| IQVIA Holdings, Inc. NYSE:IQV | 67,768 | US$15.9M | 1.3% | New | Jul 31, 2026 |
| Ucb S.A. EURONEXT:UCB | 58,259 | US$15M | 1.2% | No change | Jul 31, 2026 |
| Ligand Pharmaceuticals Incorporated NASDAQ:LGND | 49,408 | US$14.2M | 1.2% | +3,760 | Jul 31, 2026 |
| Protagonist Therapeutics, Inc. NASDAQ:PTGX | 104K | US$14.2M | 1.2% | No change | Jul 31, 2026 |
| Natera, Inc. NASDAQ:NTRA | 52,670 | US$14.1M | 1.2% | −11,082 | Jul 31, 2026 |
| Sandoz Group Ltd SIX:SDZ | 169K | US$13.8M | 1.1% | No change | Jul 31, 2026 |
| Ascendis Pharma A/S NASDAQ:ASND | 54,101 | US$13.2M | 1.1% | −154 | Jul 31, 2026 |
| Revolution Medicines, Inc. NASDAQ:RVMD | 69,866 | US$13.1M | 1.1% | +11,302 | Jul 31, 2026 |
| Amgen Inc. NASDAQ:AMGN | 33,407 | US$12.9M | 1.1% | New | Jul 31, 2026 |
| Halozyme Therapeutics, Inc. NASDAQ:HALO | 155K | US$12.8M | 1.1% | No change | Jul 31, 2026 |
| United Therapeutics Corporation NASDAQ:UTHR | 23,038 | US$11.9M | 0.99% | No change | Jul 31, 2026 |
| Quest Diagnostics Incorporated NYSE:DGX | 50,956 | US$11.9M | 0.98% | +15,035 | Jul 31, 2026 |
| Mettler-Toledo International, Inc. NYSE:MTD | 7,844 | US$11.1M | 0.92% | −2,635 | Jul 31, 2026 |
| Charles River Laboratories International, Inc. NYSE:CRL | 47,533 | US$11.1M | 0.92% | +34,481 | Jul 31, 2026 |
| Intuitive Surgical, Inc. NASDAQ:ISRG | 30,687 | US$10.8M | 0.90% | No change | Jul 31, 2026 |
| Galderma Group AG SIX:GALD | 49,726 | US$10.8M | 0.90% | No change | Jul 31, 2026 |
| Medline Inc. NASDAQ:MDLN | 265K | US$10.4M | 0.86% | No change | Jul 31, 2026 |
| Madrigal Pharmaceuticals, Inc. NASDAQ:MDGL | 21,162 | US$9.89M | 0.82% | No change | Jul 31, 2026 |
| AstraZeneca PLC LSE:AZN | 56,196 | US$9.53M | 0.79% | −196K | Jul 31, 2026 |
| West Pharmaceutical Services, Inc. NYSE:WST | 27,934 | US$9.52M | 0.79% | New | Jul 31, 2026 |
| Labcorp Holdings Inc. NYSE:LH | 27,780 | US$8.59M | 0.71% | No change | Jul 31, 2026 |
| Lonza Group AG SIX:LONN | 12,228 | US$8.52M | 0.71% | −2,660 | Jul 31, 2026 |
| Cytokinetics, Incorporated NASDAQ:CYTK | 108K | US$8.32M | 0.69% | +59,725 | Jul 31, 2026 |
| Tenet Healthcare Corporation NYSE:THC | 31,528 | US$8.03M | 0.67% | −15,041 | Jul 31, 2026 |
| STERIS plc (Ireland) NYSE:STE | 33,121 | US$7.56M | 0.63% | No change | Jul 31, 2026 |
| Krystal Biotech, Inc. NASDAQ:KRYS | 20,337 | US$6.94M | 0.57% | New | Jul 31, 2026 |
| Arrowhead Pharmaceuticals, Inc. NASDAQ:ARWR | 81,814 | US$6.93M | 0.57% | +22,271 | Jul 31, 2026 |
| Globus Medical, Inc. NYSE:GMED | 87,598 | US$6.9M | 0.57% | No change | Jul 31, 2026 |
| Twist Bioscience Corporation NASDAQ:TWST | 74,708 | US$6.84M | 0.57% | No change | Jul 31, 2026 |
| Medpace Holdings, Inc. NASDAQ:MEDP | 11,793 | US$6.81M | 0.56% | +3,132 | Jul 31, 2026 |
| Encompass Health Corporation NYSE:EHC | 53,477 | US$5.94M | 0.49% | −33,874 | Jul 31, 2026 |
| Alignment Healthcare, Inc. NASDAQ:ALHC | 384K | US$5.71M | 0.47% | No change | Jul 31, 2026 |
| Rhythm Pharmaceuticals, Inc. NASDAQ:RYTM | 57,008 | US$5.66M | 0.47% | +26,325 | Jul 31, 2026 |
| Humana Inc. NYSE:HUM | 15,045 | US$5.47M | 0.45% | New | Jul 31, 2026 |
| Praxis Precision Medicines, Inc. NASDAQ:PRAX | 16,575 | US$5.1M | 0.42% | New | Jul 31, 2026 |
| Teva Pharmaceutical Industries Limited TASE:TEVA | 145K | US$5.06M | 0.42% | New | Jul 31, 2026 |
| Cogent Biosciences, Inc. NASDAQ:COGT | 124K | US$4.83M | 0.40% | +49,924 | Jul 31, 2026 |
| Mirum Pharmaceuticals, Inc. NASDAQ:MIRM | 45,043 | US$4.77M | 0.40% | +15,080 | Jul 31, 2026 |
| BioLife Solutions, Inc. NASDAQ:BLFS | 152K | US$4.74M | 0.39% | No change | Jul 31, 2026 |
| BillionToOne, Inc. NASDAQ:BLLN | 33,606 | US$4.66M | 0.39% | +18,838 | Jul 31, 2026 |
| Rapport Therapeutics, Inc. NASDAQ:RAPP | 110K | US$4.51M | 0.37% | No change | Jul 31, 2026 |
| LeMaitre Vascular, Inc. NASDAQ:LMAT | 44,039 | US$4.46M | 0.37% | No change | Jul 31, 2026 |
| Centene Corporation NYSE:CNC | 65,007 | US$4.04M | 0.34% | New | Jul 31, 2026 |
| RadNet, Inc. NASDAQ:RDNT | 62,732 | US$4M | 0.33% | No change | Jul 31, 2026 |
| IDEXX Laboratories, Inc. NASDAQ:IDXX | 6,940 | US$3.88M | 0.32% | −16,571 | Jul 31, 2026 |
| Glaukos Corporation NYSE:GKOS | 22,572 | US$3.76M | 0.31% | New | Jul 31, 2026 |
| Dianthus Therapeutics, Inc. NASDAQ:DNTH | 33,618 | US$3.59M | 0.30% | No change | Jul 31, 2026 |
| Xenon Pharmaceuticals Inc. NASDAQ:XENE | 52,646 | US$3.3M | 0.27% | No change | Jul 31, 2026 |
| Bruker Corporation NASDAQ:BRKR | 50,580 | US$3.18M | 0.26% | New | Jul 31, 2026 |
| Heartflow, Inc. NASDAQ:HTFL | 121K | US$3.06M | 0.25% | No change | Jul 31, 2026 |
| Tarsus Pharmaceuticals, Inc. NASDAQ:TARS | 50,546 | US$2.98M | 0.25% | No change | Jul 31, 2026 |
| Palvella Therapeutics, Inc. NASDAQ:PVLA | 20,783 | US$2.89M | 0.24% | No change | Jul 31, 2026 |
| Incyte Corporation NASDAQ:INCY | 22,546 | US$2.69M | 0.22% | New | Jul 31, 2026 |
| uniQure N.V. NASDAQ:QURE | 52,763 | US$2.3M | 0.19% | New | Jul 31, 2026 |
| Edgewise Therapeutics, Inc. NASDAQ:EWTX | 44,189 | US$1.7M | 0.14% | New | Jul 31, 2026 |
| Kiniksa Pharmaceuticals International, plc NASDAQ:KNSA | 22,546 | US$1.68M | 0.14% | New | Jul 31, 2026 |
| Phathom Pharmaceuticals, Inc. NASDAQ:PHAT | 185K | US$1.62M | 0.13% | No change | Jul 31, 2026 |
| GMR Solutions Inc. NYSE:GMRS | 121K | US$1.56M | 0.13% | New | Jul 31, 2026 |
| Mineralys Therapeutics, Inc. NASDAQ:MLYS | 56,401 | US$1.44M | 0.12% | New | Jul 31, 2026 |